Ccdc94 Protects Cells from Ionizing Radiation by Inhibiting the Expression of p53 by Sorrells, Shelly et al.
 




(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Sorrells, Shelly, Seth Carbonneau, Erik Harrington, Aye T. Chen,
Bridgid Hast, Brett Milash, Ujwal Pyati, et al. 2012. Ccdc94
protects cells from ionizing radiation by inhibiting the expression
of p53. PLoS Genetics 8(8): e1002922.
Published Version doi:10.1371/journal.pgen.1002922
Accessed February 19, 2015 10:50:50 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10533600
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAACcdc94 Protects Cells from Ionizing Radiation by









2, Michael B. Major
4, Yi Zhou
3, Leonard I. Zon
3, Rodney A. Stewart




1Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States of America, 2Department of Pediatric Oncology,
Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, 3Department of Hematology/Oncology, Children’s Hospital,
Boston, Massachusetts, United States of America, 4Department of Cell and Developmental Biology, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina,
United States of America, 5Bioinformatics Shared Resource, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States of America
Abstract
DNA double-strand breaks (DSBs) represent one of the most deleterious forms of DNA damage to a cell. In cancer therapy,
induction of cell death by DNA DSBs by ionizing radiation (IR) and certain chemotherapies is thought to mediate the
successful elimination of cancer cells. However, cancer cells often evolve to evade the cytotoxicity induced by DNA DSBs,
thereby forming the basis for treatment resistance. As such, a better understanding of the DSB DNA damage response
(DSB–DDR) pathway will facilitate the design of more effective strategies to overcome chemo- and radioresistance. To
identify novel mechanisms that protect cells from the cytotoxic effects of DNA DSBs, we performed a forward genetic screen
in zebrafish for recessive mutations that enhance the IR–induced apoptotic response. Here, we describe radiosensitizing
mutation 7 (rs7), which causes a severe sensitivity of zebrafish embryonic neurons to IR–induced apoptosis and is required
for the proper development of the central nervous system. The rs7 mutation disrupts the coding sequence of ccdc94,a
highly conserved gene that has no previous links to the DSB–DDR pathway. We demonstrate that Ccdc94 is a functional
member of the Prp19 complex and that genetic knockdown of core members of this complex causes increased sensitivity to
IR–induced apoptosis. We further show that Ccdc94 and the Prp19 complex protect cells from IR–induced apoptosis by
repressing the expression of p53 mRNA. In summary, we have identified a new gene regulating a dosage-sensitive response
to DNA DSBs during embryonic development. Future studies in human cancer cells will determine whether pharmacological
inactivation of CCDC94 reduces the threshold of the cancer cell apoptotic response.
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Introduction
After cells undergo genotoxic stress, multiple DNA-damage
response (DDR) pathways are essential for the faithful replication
and transmission of chromosomes to subsequent generations.
Depending on the type of lesion, different pathways are engaged to
repair the DNA [1]. One of the most detrimental lesions to occur
upon exposure to ionizing radiation (IR) and certain chemother-
apies is the DNA double-stranded break (DSB). Immediate cell
cycle arrest following DNA DSBs plays a critical role in promoting
efficient DNA repair before cells enter mitosis. When exposed to
excessive amounts of DNA DSBs that overwhelm their repair
machinery, cells that are competent to do so will undergo p53-
dependent apoptosis [2]. While the exact events that determine
how this decision is made are not well understood, it is clear that
p53-mediated transcriptional induction of the BH3-only protein
Puma is critical for IR-induced apoptosis [3–5]. Puma induction
triggers the activation of Bax and Bak [6] leading to mitochondrial
outer membrane permeabilization, release of apoptotic factors
including cytochrome C, and activation of the Caspase cascade of
proteolytic degradation. Once Caspases are activated, an irrevers-
ible program of cellular destruction ensues. Anti-apoptotic
members of the Bcl-2 family of proteins, like Bcl-2 and Bcl-xL,
can inhibit this process by binding and sequestering Puma (and
other BH3-only proteins) to prevent activation of Bax/Bak.
Consequently, mutations that lead to the overexpression of Bcl-2
or to the impairment of the p53 pathway play pivotal roles not
only in the development and progression of cancer, but also in the
resistance to chemo- and radiotherapy that develops in established
tumors [2,7].
Interestingly, a number of genes with prominent functions in the
DSB-DDR pathway are also required for normal development of
the nervous system [8]. Ataxia-Telangiectasia (A–T) was one of the
earliest recognized diseases that arise from defects in the DSB-
DDR pathway and is characterized by severe ataxia, radiosensi-
tivity, defective immune function, sterility and predisposition to
cancer [9]. A–T is caused by homozygous recessive mutations in
ataxia-telangiectasia mutated (ATM) [10], a gene encoding a kinase
that plays pivotal roles in sensing DNA DSBs and coordinating a
complex cellular signaling response that mediates the commitment
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Developing neurons are highly proliferative and the associated
increase in oxidative stress likely exposes them to excessive DNA
damage, thereby explaining their unique sensitivity to defects in
the DSB-DDR pathway [8]. Since p53-dependent apoptosis is a
common consequence of excessive DNA damage in this tissue [2],
developing neurons are selectively dosage-sensitive to IR. Indeed,
we and others have shown that the developing nervous system in
zebrafish represents an excellent system to identify genes required
for the DSB-DDR [3–4,12].
The DSB-DDR pathway is complex and remains incompletely
understood [13]. ENU-based genetic screens provide an unbiased
method for identifying new components of the DSB-DDR
pathway whose inactivation could kill cells that have become
resistant to DNA-DSB-inducing therapies. To date, there are no
published accounts of forward genetic screens performed in
vertebrate in vivo models designed to identify novel radioprotective
genes. Here we describe a rapid, thirty-hour zebrafish screen to
identify mutations that enhance apoptosis after exposure to
moderate levels of IR. One of the mutants we identified from
this screen, which we named radiosensitizing mutation 7 (rs7), causes a
severe sensitivity of zebrafish embryonic neurons to IR-induced
apoptosis and is required for the proper development of the central
nervous system. Hypersensitivity to DNA-DSBs by rs7 arises from
an increase in p53 mRNA expression and activity. We have
mapped the rs7 mutation to an early stop codon within ccdc94,a
gene that encodes a protein with few known functions or
informative domains but that is highly conserved from yeast to
humans [14]. Using biochemical and genetic approaches, we
demonstrate that Ccdc94 is a functional component of the Prp19
complex in vertebrate cells. Prp19 complex members have
established roles in pre-mRNA splicing [15–16] and DNA repair
[17]. We show that depleting components of this complex renders
cells more sensitive to DNA damage because of inappropriately
high p53 mRNA and protein levels, but this effect does not arise
from a global splicing defect. In summary, by taking advantage of
the powerful embryonic and genetic attributes of the zebrafish
system, we have identified a new gene regulating a dosage-sensitive
DSB-DDR pathway during development.
Results
To discover novel radioprotective genes using the zebrafish
genetic model, we first sought to identify an obvious bright-field
phenotype in embryos that distinguishes different levels of
apoptotic response to IR. High doses of IR, such as 15 Gy,
administered to a transparent zebrafish embryo at 24 hours post-
fertilization (hpf) cause extensive apoptosis in neural tissue
resulting in the accumulation of opaque tissue in the head. This
phenotype is very consistent and readily observable by bright-field
microscopy by six hours post-IR (hpIR, Figure 1A, arrowheads).
We treated wild-type zebrafish embryos with different levels of IR
and found that the opaque tissue in the head was not observed
using doses less than or equal to 8 Gy. These data show that a
threshold of IR exposure exists between 8 and 15 Gy in wild-type
embryos that gives rise to the obvious opaque neural tissue
phenotype. We then reasoned that any mutation that inactivates a
radioprotective gene should sensitize the embryonic neural tissue
such that exposure of embryos to 8 Gy would cause a phenotype
reminiscent of 15 Gy.
Based on this logic, we performed a recessive genetic screen
using 8 Gy IR (Figure S1) and identified a number of mutations
that sensitize embryos to IR. The first mutation we characterized
was rs7 (Figure 1B) because these mutants showed a pronounced
response to 8 Gy IR. The rs7 mutation gives rise to a homozygous
recessive radiosensitive phenotype. Embryos that are heterozygous
for the rs7 mutation are phenotypically identical to homozygous
wild-type embryos with reference to all of the assays performed in
this study. To verify that the observed neural cell death in
irradiated rs7 mutants was due to apoptosis, we fixed the embryos
at six hpIR and performed immunofluorescence with an antibody
to detect activated Caspase-3 (Figure 1C). Wild-type embryos
showed moderate levels of activated-Caspase-3-positive apoptotic
cells in the brain and spinal cord in response to 8 Gy IR. By
comparison, irradiated rs7 mutants showed a dramatic increase in
cell death in the neural tissue when compared to wild-type
irradiated embryos (Figure 1C, arrowheads). We also occasionally
noticed an increase in IR-induced apoptosis in the intermediate
cell mass (ICM) where primitive hematopoietic tissue resides
(Figure 1C, arrows), but we remained focused on analyzing the
consistent neural radiosensitive phenotype. Unirradiated rs7
mutant embryos exhibited a level of apoptosis in neural tissue
that appeared similar to that of irradiated wild-type embryos
indicating that the rs7 mutation also causes apoptosis in neural
tissue independent from IR. For clarity, this will subsequently be
referred to as ‘‘rs7-mediated neurodegeneration.’’
Since radiosensitization is characterized by a multiplicative,
rather than additive, effect on the response to IR, we questioned
whether the enhanced apoptosis in the irradiated rs7 mutants
represented a true radiosensitization or simply an addition of rs7-
mediated neurodegeneration to the apoptosis that is normally
induced by 8 Gy IR. To address this question, we quantified levels
of fluorescence in each of the four experimental groups from
Figure 1C and plotted the values in Figure 1D, normalizing the
response of irradiated wild-type embryos to one. As suggested by
Figure 1C, unirradiated rs7 mutants showed levels of fluorescence
that were not significantly different from those of irradiated wild-
type embryos. Notably, compared to irradiated wild-type embryos,
irradiated rs7 mutants have a 95-fold increase in activated-
Caspase-3 staining. These data show that rs7 is a bona fide
radiosensitizing mutation.
Author Summary
Radiation therapy and most chemotherapies elicit cancer
cell death through the induction of excessive DNA
damage. However, cancer cells can harbor genetic defects
that confer resistance to these therapies. To identify
cellular components whose targeted therapeutic inactiva-
tion could potentially enhance the sensitivity of treatment-
resistant cancer cells to DNA–damaging therapies, we have
chosen an unbiased genetic approach in live whole
zebrafish embryos to identify genes that normally protect
cells from the lethal effects of DNA damage. This approach
has yielded the discovery of a novel radioprotective gene
called ccdc94. Upon inactivation of ccdc94, cells become
more sensitive to radiation-induced cell death. Our further
analysis revealed that the Ccdc94 protein functions in the
Prp19 complex, which is known to regulate gene
expression and repair of damaged DNA. We found that
this complex normally represses radiation-induced cell
death by inhibiting the expression of the p53 gene, a
critical mediator of DNA damage–induced cell death.
Future experiments that inactivate Ccdc94 and Prp19
complex proteins in human cancer cells will determine if
inactivation of this complex represents a novel therapeutic
strategy that could increase p53 expression to enhance
sensitivity to DNA damaging therapies in chemo- and
radio-resistant cancer cells.
Ccdc94 Is a Novel Radioprotective Gene
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generation is a relatively common event in zebrafish ENU-
mutagenesis screens [18–19], we found that only 11% (4/36) of
the neurodegenerative mutants we identified also gave rise to a
radiosensitizing phenotype. Conversely, we have also identified
radiosensitizing mutations that do not affect the survival of neural
tissue at 30 hpf (our unpublished data). Indeed, morpholino
knockdown of known components of the DSB-DDR pathway also
leads to radiosensitization of neural tissue with or without
associated developmental neurodegeneration ([20–21], our un-
published observations). This suggests that sensitivity to IR is not a
frequent consequence of compromised survival in neural cells.
Genetic linkage analysis of the rs7 phenotype to 239 microsat-
ellite markers revealed that markers z58296 and z7358 flanked a
2.1 centimorgan region on chromosome 2 that harbored the rs7
mutation (Figure 2A). Only 40 genes were annotated between
these markers in the available zebrafish genome assembly Zv7
(http://www.ensembl.org/Danio_rerio), and none of these genes
were implicated in the DSB-DDR response pathway. We reasoned
that the gene harboring the rs7 mutation should be expressed in
the brain and spinal cord because these tissues were selectively
radiosensitized in rs7 mutants. Using published gene expression
data for the 40 genes in the interval, we narrowed our list of
candidates to six genes based on high levels of RNA expression in
Figure 1. Identification of radiosensitizing mutation #7. (A) Wild-type AB strain embryos were exposed to the indicated amount of IR at 24 hpf
and visualized by brightfield microscopy 6 hours later. A threshold of IR exists between 8 and 15 Gy that gives rise to obvious cell death (seen as
opaque tissue, marked by arrowheads) in the brain. (B) Wild-type embryos (derived from crossing wild-type parents) or rs7 mutant embryos (derived
from crossing rs7 heterozygous parents) were exposed to 8 Gy IR at 24 hpf and visualized by brightfield microscopy 6 hours later. Arrowheads in the
rs7 mutant mark cell death reminiscent of exposure of wild-type embryos to 15 Gy (as shown in A) (C) Embryos in (B) were sorted by phenotype, fixed
at 6 hpIR and analyzed by immunofluorescence to detect activated Caspase-3. The ‘‘curly-up’’ tail phenotype and opaque tissue in the head were
used to identify rs7 mutants. These phenotypes are present (to different degrees of severity) in both unirradiated and irradiated mutants such that
they can be readily distinguished from siblings and wild-type at 30 hpf. After fixation of mutants, tails were clipped to distinguish them from wild-
type embryos, which were analyzed in the same tube for Caspase-3 activity. Embryos were grouped for analysis according to whether embryos were
irradiated or not, and rs7 mutants were identified based on the presence of tail-clips. Arrowheads point to the enhanced apoptosis in the spinal cord
of an rs7 mutant, and arrows point to increased apoptosis in the ICM region of an rs7 mutant. (D) Immunofluorescence in the spinal cords from at
least 10 embryos per group in (C) was quantified. wt; wild-type. See also Figure S1.
doi:10.1371/journal.pgen.1002922.g001
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PLOS Genetics | www.plosgenetics.org 3 August 2012 | Volume 8 | Issue 8 | e1002922Figure 2. The rs7 phenotype is caused by a mutation in the ccdc94 gene. (A) The rs7 mutation was localized to a 2.1 cM region (compared to
the Massachusetts General Hospital genetic map for linkage group 2) as defined by flanking markers z58296 and z7358. (B) Sequencing of candidate
genes (based on gene expression profiles) revealed a premature stop codon in the ccdc94 gene. Sequence from the ccdc94 gene exon 4 is shown for
an rs7 mutant, an unrelated wild-type AB embryo, and a heterozygous parent of the rs7 mutant. Asterisk indicates the rs7 point mutation, and box
illustrates mutation to a TGA nonsense codon. (C) Wild-type AB strain or rs7 heterozygous fish were incrossed, and the progeny were injected with
mRNA encoding the indicated genes at the one-cell stage of development. At 24 hpf, embryos were exposed to 8 Gy IR and visualized by brightfield
microscopy 6 hours later. (D) Embryos were injected similar to (C) but were not irradiated. Instead, they were left to develop until 48 hpf. (C and D)
Because rs7 mutant and sibling embryos injected with wild-type ccdc94 mRNAs were morphologically indistinguishable, pictures were taken first, and
the embryos were subsequently genotyped to identify mutants. (E) Wild-type embryos were injected with 400 mM mismatch morpholino (mm) as a
Ccdc94 Is a Novel Radioprotective Gene
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pubview2.apg&OID=ZDB-PUB-040907-1). We sequenced five
of these genes and found a premature stop codon in coiled-coil
domain containing gene 94 (ccdc94, R125Stop, Figure 2B).
The Ccdc94 gene is present in genomes from yeast to humans
(http://www.ensembl.org/Danio_rerio/Gene/Summary?g=ENS
DARG00000026185;r=2:52746237-52760438) and has previously
been shown to regulate pre-mRNA splicing [14]. While the
zebrafish and human protein sequences share 67% overall identity
(Figure S2), the first 175 amino acids are nearly an exact match
(94% identity). The Ccdc94 protein contains three predicted coiled-
coil domains (http://www.ensembl.org/Danio_rerio/Transcript/
Summary?g=ENSDARG00000026185;r=2:52746237-52760438;
t=ENSDART00000036813), all of which would be either
eliminated or disrupted by the R125Stop mutation, suggesting that
the R125Stop mutation interrupts a highly conserved function of
Ccdc94.
To determine if the R125Stop mutation caused the rs7
radiosensitivity phenotype, we tested whether wild-type ccdc94
mRNA could rescue the excessive IR-induced apoptosis in rs7
mutants. We injected one-cell stage wild-type embryos, or embryos
derived from a cross between rs7 heterozygotes, with mRNAs
encoding either zebrafish ccdc94, human CCDC94 or egfp (control).
We irradiated the clutches with 8 Gy and found that both
zebrafish ccdc94 and human CCDC94 mRNA rescued the rs7
bright-field radiosensitization phenotype (Figure 2C). We also
followed the development of rs7 mutant embryos in the absence of
IR and found that the rs7 mutation causes major deterioration of
neural tissue resulting in a small head and curled tail phenotype by
day 2 (Figure 2D, Figure S3) and death by the end of day 3. To
prove that this phenotype was also caused by the mutation in
ccdc94, we performed the rescue experiment described above, but
instead of irradiating the embryos at 24 hpf, we allowed them to
develop unperturbed until 48 hpf. Figure 2D demonstrates that
both zebrafish ccdc94 and human CCDC94 mRNA rescued the rs7
morphological phenotype at 48 hpf. Ultimately, however, this
transient rescue (injected mRNA generally lasts for up to three
days) did not rescue these embryos from lethality, as they
eventually succumbed to complications from developing edema
and overall dysmorphic effects by day 6 (data not shown).
Nonetheless, these data demonstrate that the early embryonic
radiosensitizing and neurodegenerative phenotypes of rs7 mutants
are specifically due to the loss of a highly conserved function of
Ccdc94.
To independently show that loss of the ccdc94 gene causes the
rs7 phenotype, we knocked-down the endogenous ccdc94 in wild-
type animals with an anti-sense translation-blocking morpholino.
Figure 2E–2F demonstrates that ccdc94 knockdown radiosensitizes
embryos as measured by whole-mount immunofluorescence to
detect activated Caspase-3. Since the ccdc94 knockdown only
increases Caspase-3 activity by 34-fold (compared to 95-fold in rs7
mutants, Figure 1D), the morpholino likely induces a partial
knockdown of Ccdc94. While the ‘‘curly-up’’ phenotype seen in
the rs7 mutants (Figure 1B, Figure 2C–2D) is not obvious at 27 hpf
in ccdc94 morphants, it becomes prominent by 2 days-post-
fertilization (data not shown). As such, we have confirmed by three
independent assays that the rs7 phenotype is due to the effects of a
recessive loss-of-function mutation in the ccdc94 gene.
The anti-apoptotic oncoprotein Bcl-2 has been shown in a
number of studies to confer cancer-cell resistance to IR and
chemotherapy [22–24]. To determine whether the rs7 mutation
could overcome bcl-2 overexpression and restore apoptosis after
exposure to IR, we injected one-cell stage wild-type or rs7 mutant
embryos with 5 pg of bcl-2 mRNA. Figure S4 shows that while
5p g o f bcl-2 mRNA completely abolishes all apoptosis in
irradiated wild-type embryos, it cannot achieve the same response
in rs7 mutant animals, which exhibit typical levels of IR-induced
apoptosis despite overexpression of bcl-2 mRNA. However, since
rs7 mutants injected with 5 pg of bcl-2 mRNA exhibit less apoptosis
than control-injected rs7 mutants (Figure S4), we hypothesized that
higher levels of bcl-2 expression would fully block rs7-mediated
radiosensitivity. Indeed, injection of 50 pg of bcl-2 mRNA (or
mRNA encoding bcl-xL, another anti-apoptotic member of the
Bcl-2 family) was able to completely block the rs7-mediated
radiosensitization. These experiments indicate that Ccdc94 is a
dose-dependent modifier of the anti-apoptotic function of bcl-2 in a
manner that is genetically upstream of bcl-2 in the DSB-DDR
pathway.
Since the only described function for Ccdc94 involved the
regulation of splicing in yeast [14], we investigated if it played a
similar role in vertebrates. We sequenced the transcriptome of
30 hpf wild-type, rs7 siblings and rs7 mutants by Illumina RNA-
Seq analysis and compared gene expression profiles. We found no
obvious global differences in splicing since greater than 96% of
genes showed no significant differences (i.e., p.0.05) in mRNA
expression, and there was no evidence of changes to alternative
splicing. Instead we found a remarkable increase in p53 mRNA
levels that were 3.4 and 5.1-fold higher in rs7 mutants compared to
rs7 siblings and wild-type embryos, respectively. These results were
confirmed by quantitative real-time reverse transcriptase PCR
(qPCR) and whole-mount in situ hybridization with a probe
complementary to p53 mRNA (Figure 3A, 3B). Interestingly, the
high expression of p53 in both the neural and hematopoietic tissue
in rs7 mutants (Figure 3B) mirrors the high expression of ccdc94 in
these same tissues in wild-type embryos (http://zfin.org/cgi-bin/
webdriver?MIval=aa-pubview2.apg&OID=ZDB-PUB-040907-1
and data not shown). To determine if elevated p53 mRNA levels
were likely due to either increased p53 transcription or enhanced
mRNA stabilization, we measured levels of intronic p53 sequence
as a representation of pre-mRNA. Indeed, rs7 mutants show a
similar increase in p53 pre-mRNA (Figure 3C) suggesting that the
elevated levels of p53 are likely due to increased transcription.
Robu et al [25] have demonstrated the activation of a p53-
dependent ‘‘general stress response’’ driven by morpholino off-
target effects. While this pathway likely required the post-
translational activation of p53, rather than upregulation of p53
transcription, we were concerned that induction of full-length p53
mRNA in rs7 mutants could be a downstream feed-forward
mechanism of the p53-dependent general stress response. We
tested this possibility by performing the same experiments in a p53
mutant background (p53
e7/e7, [26]) to eliminate the transcriptional
activity of the p53 protein. Analysis of rs7;p53 double mutants
showed that p53 mRNA remains highly elevated in this context
and is not simply an indirect consequence of a general p53-
dependent stress response (Figure 3D).
We next sought to clarify whether the increased p53 mRNA in
rs7 mutants was due to specific regulation of p53 transcription or a
negative control, or a translation-blocking ccdc94 morpholino (ccdc94 atg). Embryos were then irradiated at 24 hpf with 8 Gy IR and analyzed three
hours later by immunofluorescence to detect activated Caspase-3. (F) Embryos in (E) were quantified similar to Figure 1D. Comparisons between
mismatch morpholino-injected embryos plus and minus IR generated a p value of 0.0114. See also Figures S2 and S3.
doi:10.1371/journal.pgen.1002922.g002
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question, we first tested wild-type embryos for IR-mediated
induction of p53 mRNA. We found that IR exposure in wild-
type embryos leads to an increase in p53 mRNA expression
(Figure S5A) that is modest compared to unirradiated rs7 mutants
(Figure 3A). We next analyzed the rs7 mutants for upregulation of
genes that are known to be induced by IR-induced activation of
E2F1 in a p53-independent manner, such as apaf1, caspase7, and
p73 [27]. To measure p53-independent gene expression, we
performed the experiment in the p53
e7/e7 background. Figure S5B
demonstrates that none of these genes are significantly upregulated
by the rs7 mutation. These experiments suggest that the rs7
mutation specifically induces p53 expression through a selective
mechanism that is not simply due to general activation of the DSB-
DDR pathway.
To determine whether the increased p53 mRNA in rs7 mutants
translated to increased p53 protein, we analyzed protein levels in
rs7 siblings and mutants by western analysis using a previously
described antibody to zebrafish p53 (ZFp53-9.1, [28]). Indeed, we
found that the rs7 mutation caused a dramatic increase in p53
protein compared to siblings (Figure 3E). A previously character-
ized p53 morpholino [26] was included to demonstrate antibody
Figure 3. The rs7-mediated radiosensitizing phenotype is caused by an increase in p53 mRNA expression. (A) Thirty hpf rs7 siblings and
mutants were identified based on morphology (similar to 1C). RNA was isolated, reverse transcribed using oligo-dT primers and analyzed for the
expression of p53 mRNA by qPCR. Expression of the gapdh gene was also analyzed to normalize p53 mRNA levels. All data was then compared to
sibling data, which was adjusted to a value of one. (B) rs7 siblings and mutants were grown to 24 hpf and analyzed by whole-mount in situ
hybridization with a probe complementary to p53 mRNA. High levels of p53 mRNA expression are evident in neural tissue (arrowheads) and the ICM
(arrows). Pictures were taken first, and the embryos were subsequently genotyped to identify mutants and heterozygous or wild-type siblings. (C)
RNA from (A) was reverse transcribed with random hexamers, and intron 9 of the p53 gene was analyzed by qPCR to determine levels of p53 pre-
mRNA. Expression of 28S RNA was also analyzed to normalize p53 pre-mRNA levels. Similar results were obtained from an analysis of intron 4 (data
not shown). All data was then compared to sibling data, which was adjusted to a value of one. (D) rs7
+/2;p53
e7/e7 fish were incrossed to analyze rs7
siblings and mutants in a p53 homozygous mutant background. Rs7 mutants and siblings were distinguished by morphology since loss of p53 does
not prevent the rs7-mediated ‘‘curly-up’’ tail phenotype. RNA was harvested at 30 hpf and analyzed as in (C). (E) Protein was harvested from rs7
siblings and mutants, and p53 and control morphants (injected at 400 mM) at 30 hpf and analyzed for p53 and Tubulin (as a loading control). ImageJ
software was used to quantify band intensity from film. Shown below the blot are values for p53 divided by values for Tubulin (corresponding to
above lanes) with rs7 siblings normalized to one. (F) rs7 sibling or mutant embryos were irradiated at 24 hpf with 8 Gy IR and analyzed 2 h later by
whole-mount in situ hybridization with a probe complementary to puma mRNA. Arrowheads point to puma expression in neural tissue. (G) rs7 sibling
or mutant embryos in the p53 wild-type or homozygous mutant background were irradiated at 24 hpf with 8 Gy IR and analyzed three hours later by
immunofluorescence to detect activated Caspase-3. For panels (A), (C), and (D), error bars represent the standard error of the mean from at least three
independent experiments. Panels (B) and (F–G) show representative data from at least three independent experiments. RT; reverse transcriptase. See
also Figures S4, S5, S6.
doi:10.1371/journal.pgen.1002922.g003
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expression was likely not contributing to increased p53 protein
levels since mdm2 mRNA levels were 1.5- and 1.2-fold higher in rs7
mutants than in rs7 siblings and wild-type embryos, respectively.
These experiments define a new role for Ccdc94 in embryonic
development as a negative regulator of p53 mRNA and protein
expression.
We next questioned whether an increase in p53 protein activity
accounts for the extreme radiosensitivity of the rs7 mutants to IR.
Since p53-dependent puma induction is essential for IR-induced
apoptosis in mammals and zebrafish [4–5,29], we analyzed
expression of puma mRNA as a measure of p53 transcriptional
activity. As expected, after exposure to IR, puma expression is
much stronger in rs7 mutants than siblings (Figure 3F), and the
expression of puma in irradiated mutants and siblings requires wild-
type p53 (data not shown). To validate the requirement for p53 in
rs7-mediated radiosensitization, we tested the rs7 mutation in the
p53 mutant background. We irradiated embryos at 24 hpf,
analyzed them three hours later for apoptosis, and found that
wild-type p53 is required to execute the rs7-mediated radiosensi-
tivity (Figure 3G). These experiments suggest that the rs7-
dependent increase in p53 protein and IR-induced activity
accounts for the rs7-mediated radiosensitivity of developing neural
tissue.
In the absence of IR, rs7 mutants show increased puma expression
in neural tissue (Figure 3F, arrowheads) compared to siblings, a
sign that increased p53 mRNA expression translates to an increase
in p53 pro-apoptotic activity even in the absence of an exogenous
DNA-damage signal. Overexpression of puma has been shown to
have a potent pro-apoptotic effect in zebrafish embryos [3,12], so
we questioned whether this might contribute to the developing
neurodegenerative phenotype that becomes strikingly evident by
day 2 in rs7 mutants (Figure 2D, Figure S3 (arrowheads)). We
found that expression levels of puma were extremely high in rs7
mutants as measured at 32 hpf and 48 hpf by qPCR, and this
aberrant expression was entirely dependent on the presence of
wild-type p53 (Figure S6A). In p53 mutants, where puma expression
was absent, there was a marked reduction in neural cell death and
an obvious improvement in brain development in rs7 mutants by
brightfield microscopy (Figure S6B, arrows). While loss of wild-
type p53 prolonged the life of rs7 mutants by 2–3 days, it ultimately
failed to rescue the developmental lethality (data not shown)
indicating that Ccdc94 also has essential p53-independent roles in
development. However, these data show that inactivation of p53
significantly rescues the developmental neurodegeneration in rs7
mutants, and the pro-apoptotic activity of Puma likely contributes
to rs7-mediated neurodegeneration.
To gain further insight into the molecular function of Ccdc94 in
the DSB-DDR pathway, we performed a tandem-affinity purifi-
cation followed by mass spectrometry (TAP/MS) of human
CCDC94 in mammalian cells. Specifically, CCDC94 cDNA was
cloned into the pGlue vector encoding a dual-affinity tag
containing streptavidin-binding protein, calmodulin-binding pro-
tein, and the hemagglutinin epitope. Lines of 293T cells expressing
low levels of the tagged-bait fusion proteins were generated,
detergent-solubilized, subjected to two rounds of affinity purifica-
tion, trypsinized and analyzed by liquid chromatography–tandem
mass spectrometry. The top hit was CCDC94 (Figure 4A) which
serves as a positive control for the analysis. Interestingly, some of
the other highly significant hits (PRP19, CDC5L, PLRG1,
BCAS2) are core members of the PRP19 complex [30–32] which
has previously been shown to be required for pre-mRNA splicing
in yeast [15–16] and for DNA repair in both yeast and human
cells [33–37].
As an independent validation that Ccdc94 interacts with Prp19
complex members, we analyzed whether ccdc94 could genetically
interact with prp19 or plrg1 in vivo. We reasoned that targeting each
gene by morpholino knockdown would allow us to titrate levels of
each protein to best reveal a potential genetic interaction. We
designed a splice-blocking morpholino targeting prp19 (called prp19
e3i3, Figure S7) and made use of a previously characterized
translation-blocking plrg1 morpholino [38]. We injected the
highest dose of each morpholino that gave rise to minimal
apoptosis or developmental abnormalities. At 22 hpf, injection
with ccdc94 or prp19 morpholino alone gave rise to mostly normally
developing embryos whereas the plrg1 morpholino alone led to an
accumulation of cell death in the central nervous system in about
half of injected embryos with varying severity (represented in
Figure 4B and quantified in Figure 4D), similar to plrg1 mutants
[39] and previously characterized morphants [38]. Strikingly,
these same developmental abnormalities were highly abundant
among embryos co-injected with ccdc94 morpholino and either
prp19 or plrg1 morpholinos (Figure 4B–4D). These experiments
indicate that ccdc94 genetically interacts with both prp19 and plrg1
in vivo.
To determine whether the radioprotective function of Ccdc94 is
derived from its interaction with the Prp19 complex, we
questioned whether loss of prp19 or plrg1 could phenocopy the
rs7 mutation. We injected the prp19 morpholino into wild-type
embryos and analyzed expression of p53 mRNA by qPCR. To
ensure that we were analyzing full-length p53 mRNA and not a
truncated isoform that has been shown to be non-specifically
induced by morpholino off-target effects [25], we used primers
that were designed to amplify across exons 1 and 2 of the p53
mRNA. The ccdc94 morpholino and a mismatch morpholino were
injected as positive and negative controls for induction of p53
mRNA, respectively. The prp19 morpholino independently caused
a significant increase in p53 mRNA and pre-mRNA expression,
similar to knockdown of ccdc94 (Figure 5A–5B). Of note,
upregulation of p53 transcripts in the ccdc94 and prp19 morphants
was reduced compared to that observed in the rs7 and plrg1
mutants, likely due to incomplete knockdown by the morpholinos.
We next took advantage of a plrg1 mutant zebrafish line
[plrg1(hi3174aTg), [39]]. This line contains a retroviral insertion in
intron 1 of the plrg1 gene that leads to severely reduced mRNA
levels (Figure S8A). Embryos that are homozygous for this
retroviral insertion exhibit major developmental cell death in the
central nervous system and usually die by the end of day two [39].
Injection of wild-type plrg1 mRNA completely rescued this
developmental phenotype at 24 hpf (Figure S8B). We analyzed
p53 mRNA and pre-mRNA levels in the plrg1 mutants and found
that, similar to the rs7 mutants, they express abnormally high levels
of p53 mRNA and pre-mRNA (Figure 5C–5D).
We reasoned that the increase in p53 expression in response to
knockdown or loss of prp19 and plrg1, respectively, should lead to
an increase in IR-induced apoptosis, similar to knockdown or loss
of ccdc94 (Figure 2E–2F and Figure 1C, respectively). Since the
plrg1(hi3174aTg) mutants have severe neurodegeneration that
interfered with our ability to evaluate irradiated embryos for an
increase in apoptosis, we elected to use the plrg1 morpholino [38]
to titrate plrg1 expression levels. We first analyzed whether
knockdown of prp19 and plrg1 would phenocopy the rs7-mediated
increase in p53 protein expression seen in Figure 3E. Figure 5E
shows that knockdown with either the prp19 e3i3 or plrg1 atg
morpholinos caused an increase in p53 expression that was
specifically rescued by overexpression of the respective wild-type
mRNAs. Knockdown of either prp19 or plrg1 also sensitized the
embryos to IR-induced apoptosis (Figure 5F–5G). Together these
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which functions to protect proliferating embryonic neural cells
from genotoxic stresses such as IR by modulating the levels of p53
mRNA expression (Figure 5H).
Discussion
We have previously shown that zebrafish embryonic neural
tissue is an excellent model system to dissect the DSB-DDR
pathway since it faithfully recapitulates many of the complex
molecular signaling events elucidated in mammalian systems
[4,12]. With the notion that conserved embryonic pathways are
exploited by cancer cells to promote survival, we embarked on a
unique approach to use an unbiased genetic screen in zebrafish to
identify novel radioprotective genes in the DSB-DDR pathway.
The goal of these studies is to better understand the role of the
DSB-DDR pathway in development, knowledge that can be
ultimately translated to improved therapies for cancer treatment.
Our efforts led us to identify a novel radioprotective gene called
ccdc94. The Ccdc94 S. cerevisiae ortholog (named Yju2) has
previously been shown to interact with the Prp19 complex
[14,30,32] and is required for the first catalytic step in pre-mRNA
splicing in yeast [14]. Our experiments confirm that the Ccdc94/
Prp19 complex interaction is conserved in vertebrate cells;
however, we have identified a new function for this complex in
repressing p53 mRNA expression during development.
The Prp19 complex has a well-established role in pre-mRNA
splicing in yeast [15–16], but whether the complex has an
equivalent role in vertebrates is not clear [17]. Our studies show
that the Prp19 complex normally represses p53 mRNA expression
in neural cells to promote cell survival. There is a large body of
evidence documenting the regulation of p53 activity by post-
translational mechanisms [40] but a relative dearth of studies
addressing potential mechanisms by which p53 is regulated at the
transcriptional level despite the fact that potent transcriptional up-
regulation could conceivably overcome post-translational mecha-
nisms that restrict p53 activity. Indeed, we found that the 9-fold
up-regulation of p53 mRNA transcripts in rs7 mutants translates to
increased p53 activity. To date, there is no evidence to suggest that
the Prp19 complex directly regulates transcription. An analysis of
down-regulated genes in the rs7 mutants could yield novel, direct
mechanisms by which the p53 gene is transcriptionally regulated.
The Prp19 complex has also been linked to DNA repair [17].
Indeed, the prp19 gene was originally identified in S. cerevisiae in a
screen for radiosensitizing mutations [33]. The prp19 mutant
identified in this screen, initially called xs9, was subsequently
renamed pso4-1 since it was shown to have much greater sensitivity
to the DNA interstrand cross-linking (ICL) agent PAVA (psoralen
plus UVA light therapy) than to IR [34]. Further analysis of this
thermoconditional mutant revealed that Prp19 functions in repair
of DNA ICLs in a pathway that appears to be genetically
separable from its role in pre-mRNA splicing [33–34,36]. Studies
of human PRP19 confirmed the role of the PRP19 complex in
ICL repair [37] and also suggested a role for PRP19 in the repair
of DNA DSBs [35]. Therefore, the increase in p53 expression
resulting from loss of Prp19 complex gene expression could
ultimately stem from a lack of DNA repair.
The neural tissue is one of the most radiosensitive tissues in the
early developing zebrafish embryo. One likely explanation arises
from the supposition that developing neurons are already poised to
Figure 4. Ccdc94 interacts with core members of the Prp19 complex. (A) TAP/MS analysis shows that human CCDC94 binds to core members
of the PRP19 complex. ‘‘Total Peptide #’’ indicates the number of peptides present in the analysis that are derived from the indicated protein.
‘‘Coverage Percentage’’ refers to the percent of protein sequence for a given protein that is represented by the peptides. ‘‘Unique # Peptide’’ refers
to the number of unique peptides found for the indicated protein. (B, C) Wild-type embryos were injected with the ccdc94 atg morpholino (400 mM),
prp19 e3i3 morpholino (200 mM), or mismatch morpholino (as a negative control and to keep the total concentration of morpholino injections at
600 mM) and grown to 22 hpf. A range of phenotypes were observed in the embryos as shown in (B). Embryos showing the different phenotypes
from (B) were quantified in (C). (D) Wild-type embryos were injected with the ccdc94 atg morpholino (400 mM), plrg1 atg morpholino (20 mM), or
mismatch morpholino (as a negative control and to keep the total concentration of morpholino injections at 420 mM), grown to 22 hpf, and analyzed
as in (C). Data in (C) and (D) is derived from one representative experiment; however, three independent experiments were qualitatively similar for
each panel. Number (n) of embryos analyzed for each group is indicated. See also Figure S7.
doi:10.1371/journal.pgen.1002922.g004
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factors from their synaptic targets [41]. As such, readiness to
undergo DNA-damage-induced apoptosis is a feature that
embryonic neural tissue shares with many cancers [42]. The
neural tissue is also one of the most highly proliferative tissues in
the developing embryo (our unpublished observations), another
feature in common with cancer [43]. By exploiting the similarities
between embryonic neural tissue and cancer cells, we have been
able to use an unbiased genetic approach to identify novel and
conserved genes involved in the DSB-DDR that represent
potentially important targets in both neurodegenerative disease
and radio-resistant cancers.
Sensitivity to IR-induced apoptosis by the rs7 mutation appears to
be restricted to neural tissue and possibly primitive hematopoietic
tissue in the ICM (Figure 1C). These areas are consistent with
disproportionately high levels of ccdc94 mRNA expression during
zebrafish embryonic development (http://zfin.org/cgi-bin/
webdriver?MIval=aa-pubview2.apg&OID=ZDB-PUB-040907-1
and data notshown) as well as regionsofhigh p53 mRNAexpression
(Figure 3B) in rs7 mutants. In general, tissues other than neural or
ICM have modest expression of ccdc94 by comparison suggesting
that Ccdc94-independent mechanisms evolved to regulate p53
expression in these other tissues. However, CCDC94 appears to be
ubiquitously expressed in tissues of adult humans (http://www.ncbi.
nlm.nih.gov/UniGene/clust.cgi?ORG=Hs&CID=21811) suggest-
ing that it may have a broader role in the regulation of p53
expression beyond development.
In conclusion, we have identified and analyzed the role of a
novel radioprotective gene, ccdc94, in the first genetic screen in a
vertebrate system designed to identify radiosensitizing mutations in
vivo. We found that in vertebrate cells Ccdc94 interacts with core
members of the Prp19 complex both biochemically and genetically
and that protection from IR-induced apoptosis by this complex is
mediated by inhibition of p53 expression. Upregulation of p53
Figure 5. Loss of prp19 or plrg1 phenocopies, loss of ccdc94. (A) Wild-type embryos were injected with the indicated morpholinos. RNA was
harvested at 30 hpf, reverse transcribed using oligo-dT primers and analyzed for the expression of p53 mRNA by qPCR. Expression of the gapdh gene
was also analyzed to normalize p53 mRNA levels. All values were then compared to the average value from uninjected embryos, which was adjusted
to one. (B) RNA from (A) was reverse transcribed with random hexamers, and intron 9 of the p53 gene was analyzed by qPCR to determine levels of
p53 pre-mRNA. Expression of 28S RNA was also analyzed to normalize p53 pre-mRNA levels. All values were then compared to the average value from
uninjected embryos, which was adjusted to one. (C, D) Siblings and mutants from the plrg1(hi3174aTg) line were distinguished by morphology at
30 hpf and collected for analysis. RNA was harvested and analyzed by qPCR as in (A, B). For panels (A–D), error bars represent the standard error of
the mean from at least three independent experiments. (E) Wild-type embryos were injected with the indicated morpholinos and analyzed at 30 hpf
for p53 protein similar to Figure 3E. (F) Wild-type embryos were injected with the indicated morpholinos, irradiated (or not) at 24 hpf with 8 Gy and
analyzed three hours later by whole-mount immunofluorescence to detect activated Caspase-3. Three independent experiments showed that
knockdown of prp19 or plrg1 radiosensitized the embryos. (G) Activated-Caspase-3-specific immunofluorescence from (F) was quantified as in
Figure 1D. (H) Genetic diagram showing that the Ccdc94 and core members of the Prp19 complex inhibit the transcription of p53, and therefore p53-
mediated induction of puma expression, and normally restrict IR-induced mitochondrial apoptosis, upstream of Bcl-2. For all relevant panels in this
figure, morpholinos were injected at the same concentrations as described in Figure 4B-4D. RT; reverse transcriptase, mm; mismatch, ccdc; ccdc94,
prp; prp19. See also Figure S8.
doi:10.1371/journal.pgen.1002922.g005
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during cancer progression to restrict its protein activity. Future
experiments will determine whether CCDC94 and PRP19
complex components will be useful targets for sensitizing p53
wild-type cancer cells to IR therapy.
Materials and Methods
Ethics statement
All experiments involving zebrafish conformed to the regulatory
standards and guidelines of the Dana-Farber Cancer Institute and
University of Utah Institutional Animal Care and Use Committee.
Zebrafish lines
Zebrafish were maintained, mutagenized and bred as described
[44]. Wild-type embryos and the rs7 mutant line were derived
from the AB strain. The rs7 mutant line was outcrossed to wild-
type AB fish seven times and all phenotypes described herein are
representative of crosses between at least seventh generation rs7
heterozygous fish. The plrg1(hi3174aTg) line was obtained from the
Zebrafish International Resource Center (http://zebrafish.org/
zirc/home/guide.php). We have previously described the p53
e7/e7
zebrafish line that carries a homozygous M214K mutation in the
p53 coding sequence [26].
Irradiator usage
IR was administered with either a Cs-137 gamma irradiator
(Gammacell 1000) or an X-ray irradiator (RadSource RS2000).
Irradiators were completely interchangeable such that 8 Gy of X-
rays gave rise to identical embryonic phenotypes described in this
study as 8 Gy of gamma rays.
Zebrafish microinjections
Zebrafish one-cell stage embryos were injected with 500
picoliters of mRNA or the indicated concentration of morpholino.
In every experiment, total RNA or morpholino concentrations
were kept constant through the addition of egfp mRNA or a
mismatch morpholino, respectively. Morpholinos were designed
and created by GeneTools, and sequences are listed in Text S1.
For mRNA microinjection, zebrafish cDNAs were sub-cloned into
pCS2+, and mRNA was made by 1) linearization of each construct
with NotI, 2) SP6 Message Machine kit (Ambion, AM1340) and 3)
purification for microinjection with NucAway Spin Columns
(Ambion, AM10070). For morpholino rescue experiments, the
plrg1 coding sequence was mutated to prevent direct binding of
plrg1 mRNA to the translation-blocking plrg1 atg morpholino while
creating only silent changes in regard to Plrg1 amino acid
sequence (relevant primers are listed in Text S1).
Whole-mount in situ hybridization
For in situ hybridization, zebrafish cDNAs were sub-cloned into
the pGEM-T-Easy (Promega). The pGEM-puma vector and
generation of antisense probe was described previously [46]. The
full-length zebrafish tp53 coding sequence was amplified with
primers based on the published GenBank sequence (NM_131327
and Text S1). Full-length antisense and sense p53 RNA was
generated by digesting with Apa1 and EcoRI, respectively, and
transcribed in vitro with Sp6 and T3 polymerase, respectively.
Embryos were dechorionated, staged, and fixed overnight in 4%
paraformaldehyde at 4uC. Fixed embryos were washed in 16
PBST (16PBS plus 0.1% Tween-20) at room temperature (RT,
3610 minutes) and incubated in 100% methanol at 220uC for a
minimum of two hours. Embryos were rehydrated in 16 PBST
(3610 minute washes at RT) and incubated in Hyb-minus (50%
formamide, 56SSC, and 0.1% Tween-20) for one hour at 68uC,
then transferred to Hyb-plus (Hyb-minus, 5 mg/ml torula RNA
type VI, 50 ug/ml heparin) for three hours at 68uC. RNA probe
was added to embryos in Hyb-plus at 1 ng/uL and incubated
overnight at 68uC. Embryos were then subjected to 20-minute
washes at 68uC in the following order: twice with 26 SSCT-
formamide (26 SSC, 0.1% Tween-20, 50% formamide), once
with 26SSCT, twice with 0.26SSCT. At RT, embryos were then
washed (3610 minutes) with MABT (100 mM maleic acid,
150 mM sodium chloride, 100 mM Tris pH 9.5, 0.1% Tween-
20), then incubated in block [MABT, 2% Blocking Reagent
(Roche #11096176001), 1% fetal bovine serum] at RT for one
hour. Embryos were incubated overnight in 1:5000 anti-digox-
igenin-fluorescein Fab fragments (Roche #11207741910) in block
at 4uC. Embryos were then washed in 16MABT (3610 minutes
at RT) and 0.1 M Tris pH 9.5 (3610 minutes at RT) and stained
with Vector BCIP/NBT alkaline phosphatase (Roche
#11697471001). Upon completion of staining, embryos were
washed in 16PBST (3610 minutes at RT) to stop the reaction.
Embryos were imaged in either 80% glycerol or 3% methylcel-
lulose (to allow for subsequent genotyping).
Whole-mount immunofluorescence and quantitation
Whole-mount activated Caspase-3 immunofluorescence was
performed and quantified as described previously [12]. Quanti-
tation was performed after immunofluorescence experiments by
removing embryo tails at the level of the yolk. Tails were laid flat
on a petri dish in 80% glycerol and activated Caspase-3 staining
was documented by fluorescence microscopy using a Nikon
Digital Sight DS-2MBWc black and white camera. All fluorescent
pictures were taken at exactly the same exposure, gain, and
magnification. Pictures were then cropped in Adobe Photoshop
to include the same size region (using the ruler function on
Photoshop) of the spinal cord using the end of the yolk extension
as a reference point for all measurements, and to exclude any
fluorescence arising outside of the spinal cord. Quantitation of
fluorescence was performed with Volocity software by using the
‘‘Find Objects Using Intensity’’ option. The same exact
parameters for eliminating the inclusion (and therefore quanti-
tation) of background fluorescence were applied to all pictures
equally. Six to twelve embryos from each group were included for
all quantifications. GraphPad Prism software was used to plot the
data, and error bars represent the standard error of averaged data
from the embryos in a single experiment. Statistical analyses were
performed using GraphPad Prism software using an unpaired
student’s T test. Representative quantitations from at least three
experiments are shown for all data. Quantification represents
measurements of fluorescence intensity which is directly related to
Caspase-3 activity. However, fluorescence intensity is likely to
fluctuate within cells. Therefore, changes in fluorescence intensity
likely represent both increasing apoptotic cell number as well as
increasing Caspase-3 activity within cells.
RNA–Seq analysis
The transcriptome of 30 hpf wild-type, rs7 siblings and rs7
mutants was analyzed by Illumina RNA–Seq analysis. Total
RNA samples were prepared for sequencing using an Illumina
mRNA Seq Sample Prep Kit and were sequenced using standard
protocols on an Illumina Genome Analyzer IIx. Paired 36 base
pair reads were obtained from the ends of each sequenced
fragment. Reads were aligned to the Danio rerio Zv8 genome
build (release date December 2008, obtained from UCSC
Genome Bioinformatics, http://genome.ucsc.edu) with the SOA-
PAligner software (release 2.19, http://soap.genomics.org.cn/
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of 100 to 140 bp, as the mean library insert size was 120 bp.
Sequencing and alignment of the samples yielded the following in
terms of sample, read pairs, aligned reads, and percent aligned: 1)
rs7 muts, 19,034,491, 18,358,098, 96.4%, 2) rs7 sibs, 20,036,828,
19,206,760, 95.9%, 3) wild-type, 16,604,110, 12,630,153, 76.1%.
RNA–Seq data from the rs7 mutant, sibling, and wild-type
samples was analyzed for differential expression and differential
splicing using the DefinedRegionScanSeqs method of the USeq
software [45]. Transcript coordinates for this analysis were
collected from the UCSC Genome Browser database [46].
Quantitative real-time PCR
RNA was isolated from embryos (10–25 embryos/sample)
using the Qiagen RNeasy kit (74104). One microgram of
purified RNA was used to generate cDNA using the Invitrogen
Thermoscript RT-PCR kit (11146-024). For mRNA analysis,
RNA was reverse transcribed using oligo-dT primers. For pre-
mRNA analysis, RNA was reverse transcribed with random
hexamers. cDNA was diluted 1:20 in nuclease-free water and
three technical replicates were analyzed using the LightCycler
480 Probes Master PCR mix (4707494001) and the Roche 480
Light Cycler or Eppendorf Realplex. Primers were designed by
Roche to be used with their Universal Probe Library and are
listed in Text S1. Primers were designed to cross exons 1 and 2
of the p53 gene to ensure specific amplification of full-length
p53 mRNA, and expression of the gapdh gene was analyzed to
normalize p53 mRNA levels. Introns 4 and 9 of the p53 gene
were analyzed by qPCR to determine levels of p53 pre-mRNA,
and expression of 28S RNA (which does not undergo splicing)
was analyzed to normalize p53 pre-mRNA levels. All data was
averaged from at least three independent experiments.
GraphPad Prism software was used to plot the data, and error
bars represent the standard error of averaged data. Statistical
analyses were performed using GraphPad Prism software using
an unpaired student’s T test.
Tandem affinity purification/mass spectrometry analysis
CCDC94 cDNA was cloned into the pGlue vector encoding a
dual-affinity tag containing streptavidin-binding protein, calmod-
ulin-binding protein, and the hemagglutinin epitope. Lines of
293T cells expressing low levels of the tagged-bait fusion proteins
were generated, detergent-solubilized, subjected to two rounds of
affinity purification, trypsinized, and analyzed by liquid chroma-
tography–tandem mass spectrometry. Tryptic peptides were
separated by reverse phase nano-HPLC using a nanoAquity
UPLC system (Waters Inc). Peptides were first trapped in a 2 cm
trapping column (75 mm ID, C18 beads of 2.5 mm particle size,
200 A ˚ pore size) and then separated on a self-packed 25 cm
column (75 mm ID, C18 beads of 2.5 mm particle size, 100 A ˚ pore
size) at room temperature. The flow rate was 350 nl/min over a
gradient of 5% buffer B (0.1% formic acid in acetonitrile) to 40%
buffer B in 200 minutes. The identity of the eluted peptides was
determined with a Velos-Orbitrap mass spectrometer (Thermo-
Scientific). Specifically, following a FT full scan, MS
2 spectral data
were acquired by collision induced dissociation (CID) on the 9
most intense ions from the full scan, taking into account dynamic
exclusion. The polysiloxane lock mass of 445.120030 was used
throughout. All raw data were converted to mzXML format
before a semi-tryptic search of the resultant spectra using Sequest
and the Transproteomic Pipeline (TPP) on a Sorcerer 2.0 platform
(Sage N Research, Milpitas, CA).
Western analysis
Approximately 100 30-hpf dechorionated embryos were rinsed
three times at RT with 16 PBS. Ice-cold PBS was added, and
embryos were incubated on ice for 5 minutes. Embryos were then
de-yolked by pipetting 40 times through a thin bore plastic bulb
pipet (Samco 235) in ice-cold PBS. Tubes were returned to ice for
two minutes to let embryo bodies sink to the bottom of the tube.
Supernatant was removed and embryo bodies were washed three
times in ice-cold PBS, pelleted by centrifugation (1 second at top
speed), and lysed with RIPA buffer (1% Nonide P-40, 0.5%
sodium deoxycholate, 0.1% sodium dodecyl sulfate) containing
1% protease inhibitors (Sigma P8340) and 1% benzonase
(Novagen 70746-3). BCA protein assay kit (Thermo Scientific
23227) was used to determine protein concentration. Ten
micrograms of protein was loaded onto a denaturing gel (Novex
NP0301BOX) and transferred to pre-hydrated PVDF membrane
(GE PV4HYA0010). Membrane was blocked in 10% non-fat milk
diluted in tris-buffered saline plus 1% tween-20 (TBST) for anti-
p53 antibody. Zebrafish p53 antibody was kindly provided by Dr.
Lane at A*STAR, Singapore and used at 1:30 in 10% milk with
overnight incubation at 4uC. The blot was washed (465 minutes
each) in 16TBST. Anti-mouse-horseradish peroxidase secondary
antibody (Cell Signaling 7076S) was used at 1:5000 in the same
block for primary antibody. The blot was washed (465 minutes
each) in 16 TBST before chemiluminescent horseradish perox-
idase substrate (Millipore WBKLS0500) and film (Thermo
Scientific 34090) were used to detect signal. Blot was stripped
for 45 minutes rotating at 60uC (62.5 mM Tris, 2% sodium
dodecyl sulfate, 100 mM 2-mercaptoethanol) and washed
(8615 minutes at RT) in TBST. The blot was then re-blocked
in 3% bovine serum albumin (Amresco 0332) in TBST and
probed using anti-GAPDH antibody (Abcam 9484) at 1:2000 or
anti-a-Tubulin antibody (Sigma T9026) at 1:10,000. The mouse
secondary antibody and detection was performed as outlined
above. Developed films were electronically scanned at 600 dots per
inch and quantified using ImageJ software.
Supporting Information
Figure S1 Schematic of genetic screen to identify recessive
radiosensitizing mutations. Wild-type AB strain male zebrafish
were treated with ENU giving rise to approximately 192 gene-
inactivating mutations per sperm. ENU-mutagenized males were
crossed with wild-type AB strain female fish to yield the F1
generation. Each fish in the F1 generation carried 192 unique
mutations and were incrossed to create F2 families carrying 384
mutations per family. Up to eight random incrosses were
performed within each F2 family, and the F3 clutches were
subsequently analyzed for radiosensitizing phenotypes as described
in the figure.
(TIF)
Figure S2 Alignment of zebrafish, mouse and human CCDC94
protein sequences. Protein sequences from zebrafish, mouse and
human CCDC94 were aligned with the Jotun Hein algorithm
using the default parameters in Lasergene MegAlign software.
Zebrafish Ccdc94 is 67% identical to human CCDC94 and 69%
identical to mouse CCDC94. An asterisk denotes R125, the
residue that is mutated to a stop codon in rs7 mutants.
(TIF)
Figure S3 The rs7 mutation causes severe neurodegeneration
that culminates in embryonic lethality. Wild-type embryos
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brightfield microscopy on day 2 and day 3 of development. The
rs7 mutation causes massive accumulation of cell death in the
brain and spinal cord likely contributing to a small-head and
‘‘curly-up’’ tail phenotype. Rs7 mutant embryos usually fail to
survive past day three.
(TIF)
Figure S4 Loss of ccdc94 compromises the anti-apoptotic
function of Bcl-2. Wild-type (wt, derived from crossing wild-type
parents) or rs7 mutant embryos (derived from crossing rs7
heterozygous parents) were injected at the one-cell stage of
development with the indicated amounts of mRNA encoding zbcl-
2, zbcl-xL, or egfp as a control (cntl). Embryos were then irradiated
at 24 hpf with 8 Gy IR and analyzed three hours later by
immunofluorescence to detect activated Caspase-3. Mutants were
genotyped as in Figure 2C–2D. Representative data from three
independent experiments is shown.
(TIF)
Figure S5 The rs7 mutation does not appear to cause a general
activation of the DSB-DDR pathway. (A) Wild-type embryos were
exposed (or not) to 8 Gy IR at 27 hpf and harvested for analysis
three hours later. Quantitative PCR to analyze p53 mRNA
expression was performed as in Figure 3A. (B) Rs7 siblings and
mutants in the p53
e7/e7 background [26] were analyzed at 30 hpf
for expression of the indicated genes by qPCR similar to Figure 3A.
For both (A) and (B), gapdh mRNA expression was measured to
normalize gene expression levels. All data was then compared to
rs7 sibling data, which was adjusted to a value of one. None of the
values in (B) are significantly different from each other.
(TIF)
Figure S6 p53-mediated puma expression causes neurodegener-
ation in rs7 mutants. (A) rs7 sibling or mutant embryos in the p53
wild-type or mutant background were collected, and RNA was
harvested at 30 hpf, reverse transcribed and analyzed for the
expression of puma mRNA by qPCR. Rs7 mutants and siblings
were distinguished by morphology since loss of p53 does not
inhibit the rs7-mediated ‘‘curly-up’’ tail phenotype. (B) Pictures
were taken of 48 hpf embryos from (A). Arrows point to
neurodegeneration in rs7 mutants that is substantially rescued by
loss of wild-type p53. For panel (A), error bars represent the
standard error from three independent experiments.
(TIF)
Figure S7 The prp19 morpholino inhibits proper splicing of the
prp19 pre-mRNA transcript. (A) Schematic of the zebrafish prp19
gene with exons shown as boxes and introns shown as lines
between boxes. The e3i3 morpholino targets the splice donor site
at the border of exon 3 and intron 3. In (B), F1 and R2 primer-
based PCR will amplify from exon 2 to intron 3. Properly spliced
mRNA should not give rise to PCR product. Inclusion of intron 3
should give rise to a 245-basepair product. (B) RNA from embryos
injected with mismatch morpholino controls or prp19 e3i3
morpholino was harvested at 24 hpf, reverse transcribed with
oligo-dT primers, and analyzed by PCR using primers shown in
(A). Bands were excised from the gel, cloned into pGEM-T-Easy,
and sequenced. Lower-case letters point to bands on the gel which
correspond to regions of the prp19 gene shown below. When
embryos were injected with the e3i3 morpholino, F1/R2 primers
gave rise to a band representing inclusion of intron 3 (b). This
should cause premature termination the Prp19 protein since a stop
codon is present in the middle of the intron. Unexpectedly, all
samples gave rise to a 330-basepair band (a) which is likely derived
from the presence of contaminating genomic DNA but does not
change interpretation of the data.
(TIF)
Figure S8 Loss of plrg1 mRNA expression in the
plrg1(hi3174aTg) line leads to severe developmental abnormalities
characterized by excessive cell death. (A) Siblings and mutants
were collected from the plrg1(hi3174aTg) line based on morphol-
ogy. RNA was harvested from each group at 30 hpf, reverse
transcribed and analyzed by qPCR to determine levels of plrg1
mRNA. Error bars represent the standard error from three
independent experiments. (B) plrg1(hi3174aTg) heterozygous fish
were incrossed, and the progeny were either left uninjected or
injected with 100 ng/uL of the indicated mRNAs. Right panels
show higher magnification of embryos from adjacent left panels.
Overexpression of plrg1 rescues the developmental abnormalities
in the plrg1(hi3174aTg) mutants.
(TIF)
Text S1 Supplemental Experimental Procedures. (A) Primers
used for subcloning are listed and include the name of the target
gene as well as restriction sites used for directional cloning into the
pCS2+ expression plasmid. (B) The sequences of morpholinos used
in this study are listed. The plrg1 morpholino was previously
described [38]. (C) Primers used to examine specificity of the prp19
e3i3 morpholino are listed. See also Figure S7. (D) Primers used to
sub-clone zp53 into pGEM-T-Easy for use in p53 in situ
hybridization experiments are shown. See also Figure 3B. (E)
Primer/probe sets used for qPCR analysis are grouped by
presence or absence of shading.
(PDF)
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